First National Bank of Omaha Invests $3.91 Million in Revvity Inc. $RVTY

First National Bank of Omaha bought a new position in Revvity Inc. (NYSE:RVTY) during the second quarter, Holdings Channel reports. The firm bought 35,126 shares of the company’s stock, valued at approximately $3,908,000.

Several other large investors have also added to or reduced their stakes in RVTY. Ascentis Independent Advisors acquired a new position in Revvity during the 1st quarter valued at about $29,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Revvity in the second quarter worth approximately $32,000. MUFG Securities EMEA plc purchased a new stake in shares of Revvity in the second quarter worth approximately $34,000. SJS Investment Consulting Inc. lifted its holdings in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after purchasing an additional 521 shares in the last quarter. Finally, Headlands Technologies LLC bought a new position in shares of Revvity in the second quarter valued at approximately $49,000. Institutional investors own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on RVTY shares. JPMorgan Chase & Co. decreased their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a research note on Sunday. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Evercore reiterated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Finally, Barclays increased their target price on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Stock Performance

NYSE:RVTY opened at $113.99 on Wednesday. The company has a market capitalization of $12.72 billion, a P/E ratio of 54.28, a P/E/G ratio of 2.13 and a beta of 1.07. The business has a fifty day simple moving average of $110.13 and a two-hundred day simple moving average of $100.02. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.34.

Revvity (NYSE:RVTY) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The firm had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, analysts expect that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s dividend payout ratio is 13.33%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.